Όλο το DSpace

Πλοήγηση ανά Θέμα "Sodium-Glucose Transporter 2"

Αποτελέσματα 1-2 από 2

    • Mechanisms for cardiorenal protection of sglt-2 inhibitors 

      Georgianos P.I., Vaios V., Dounousi E., Salmas M., Eleftheriadis T., Liakopoulos V. (2021)
      Despite optimal treatment of diabetic kidney disease (DKD) with adequate blood pressure control and agents blocking the renin-angiotensin-system (RAS), the residual cardiorenal risk of these patients remains substantially ...

    • SGLT-2 inhibitors in diabetic kidney disease: What lies behind their renoprotective properties? 

      Georgianos P.I., Divani M., Eleftheriadis T., Mertens P.R., Liakopoulos V. (2019)
      Background: Despite optimal management of diabetic kidney disease (DKD) with intensive glycemic control and administration of agents blocking the renin-angiotensinaldosterone-system, the residual risk for nephropathy ...